Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Viking Therapeutics Inc (NASDAQ: VKTX) closed at $57.00 in the last session, down -4.01% from day before closing price of $59.38. In other words, the price has decreased by -$4.01 from its previous closing price. On the day, 2.0 million shares were traded. VKTX stock price reached its highest trading level at $60.25 during the session, while it also had its lowest trading level at $56.75.
Ratios:
We take a closer look at VKTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 29.48 and its Current Ratio is at 29.48. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on June 27, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On May 16, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $115 to $116.
Oppenheimer reiterated its Outperform rating for the stock on March 26, 2024, while the target price for the stock was revised from $116 to $138.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 03 ’24 when ZANTE GREG sold 66,756 shares for $74.69 per share. The transaction valued at 4,986,008 led to the insider holds 174,854 shares of the business.
Mancini Marianna sold 281,425 shares of VKTX for $22,136,474 on May 01 ’24. The Chief Operating Officer now owns 348,508 shares after completing the transaction at $78.66 per share. On Feb 09 ’24, another insider, Lian Brian, who serves as the President & CEO of the company, sold 45,000 shares for $29.90 each. As a result, the insider received 1,345,500 and left with 2,139,882 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 6285276160 and an Enterprise Value of 5323492864.
Stock Price History:
The Beta on a monthly basis for VKTX is 1.03, which has changed by 2.7450724 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is -6.05%, while the 200-Day Moving Average is calculated to be 38.22%.
Shares Statistics:
According to the various share statistics, VKTX traded on average about 3.42M shares per day over the past 3-months and 2439080 shares per day over the past 10 days. A total of 110.27M shares are outstanding, with a floating share count of 102.50M. Insiders hold about 7.05% of the company’s shares, while institutions hold 72.91% stake in the company. Shares short for VKTX as of 1719532800 were 16825918 with a Short Ratio of 4.92, compared to 1717113600 on 12312832. Therefore, it implies a Short% of Shares Outstanding of 16825918 and a Short% of Float of 20.57.
